Abnova is the world's largest antibody manufacturer. They have the capacity of generating 300 mouse monoclonal antibodies and 200 rabbit polyclonal antibodies per month. Rather than the traditional method of antibody production, Abnova is taking a genomic/proteomic approach for the antibody development. Their goal is to have at least one antibody to every human expressed gene in human genome. They manufacture all our products, recombinant proteins and antibodies in our state-of-the-art production and SPF animal facilities. They also have multiple clones for the monoclonal antibody, and their access is available to partners and collaborators from the academic institutions and industry.